Interstitial Pneumonitis
📧 Sign up to get email alerts when something new happens for Interstitial Pneumonitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
The TRANSPIRE study is a longitudinal pediatric HSCT cohort investigating transplant-related lung injuries. It is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade
A clinical trial using single-cell analysis to identify biomarkers of pulmonary toxicity from immune checkpoint blockade is currently recrui…
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome [Phase 4]
Phase 4 trial investigating cyclosporine A for interstitial pneumonitis associated with Sjogren's syndrome.
-
CLINICAL_TRIALS trial_result · 2020-05-15Clinical Trial Update: TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia [Phase 2]
A Phase 2 trial comparing tofacitinib plus hydroxychloroquine versus hydroxychloroquine alone in COVID-19–related interstitial pneumonitis i…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus [Phase 2, Phase 3]
Phase 2/3 trial investigating prednisolone with tacrolimus for myositis-associated pneumonitis has completed; results reported.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Rituximab in Interstitial Pneumonitis [Phase 2, Phase 3]
A clinical trial update reports completion of Phase 2 and Phase 3 studies evaluating rituximab for interstitial pneumonitis.